DAX24.475 +1,0%ESt505.383 +0,7%Top 10 Crypto15,88 +2,4%Dow45.010 +1,1%Nas21.020 +0,6%Bitcoin100.862 +0,1%Euro1,1767 ±-0,0%Öl68,99 +0,5%Gold3.371 -0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 SAP 716460 Tesla A1CX3T Deutsche Bank 514000 Mercedes-Benz Group (ex Daimler) 710000 RENK RENK73 Volkswagen (VW) vz. 766403 Lufthansa 823212 BASF BASF11 Siemens Energy ENER6Y Novo Nordisk A3EU6F BYD A0M4W9 Bayer BAY001 Clara Technologies A3E4MS
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Vor EZB-Zinsentscheid: DAX startet stark -- Asiens Börsen in Grün -- Tesla verfehlt Gewinnerwartungen - Umsatz leicht über Prognose -- Alphabet, Vodafone, BYD, Deutsche Bank, IBM im Fokus
Top News
Reckitt hebt Jahresausblick an - Gewinn gestützt durch Kostensenkungen - Aktie kräftig im Plus Reckitt hebt Jahresausblick an - Gewinn gestützt durch Kostensenkungen - Aktie kräftig im Plus
STMicro enttäuscht beim Ausblick - Chipaktien deutlich unter Druck STMicro enttäuscht beim Ausblick - Chipaktien deutlich unter Druck
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Pacific Biosciences of California Aktie

Handeln
Aktien-Sparplan anlegen
1,37 EUR -0,04 EUR -2,71 %
FSE
1,65 USD -0,05 USD -2,65 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.431,13 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1C3EQ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS69404D1081

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPACB

Pacific Biosciences of California Aktien News

DatumMeistgelesen
PR NewswireTarget ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
PR NewswireVolta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep
PR NewswirePacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
Wer­bungPacific Biosciences of California-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireAmbry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
PR NewswirePacBio Announces First Quarter 2024 Financial Results
PR NewswirePacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
PR NewswireEstonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
PR NewswirePacBio Grants Equity Incentive Award to New Employee
PR NewswirePacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
PR NewswirePacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
PR NewswirePacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
PR NewswirePacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
PR NewswirePacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
PR NewswirePacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
PR NewswirePacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
PR NewswirePacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
PR NewswirePacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
PR NewswirePacBio Announces Third Quarter 2023 Financial Results
PR NewswirePacBio Announces Appointment of David Meline to Board of Directors
PR NewswirePacBio to Report Third Quarter 2023 Financial Results on October 30, 2023
PR NewswirePacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis
PR NewswirePacBio Announces PacBio Capital
PR NewswirePacBio Announces Collaboration with Leading Library Preparation Automation Partners
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
PR NewswirePacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)
PR NewswirePacBio Announces Second Quarter 2023 Financial Results
PR NewswirePacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer
PR NewswirePacBio Begins Commercialization of the Onso Short-Read Sequencing System
PR NewswirePacBio to Report Second Quarter 2023 Financial Results on August 2, 2023
PR NewswirePacBio's Revio System Empowers Bioscientia to Scale Long-Read Whole Genome Sequencing and Unravel the Mysteries of Rare Disease
PR NewswirePacBio and Radboud University Medical Center Team Up for New Discoveries in Rare Disease Research
PR NewswirePacBio Announces the Appointment of Olga Troyanskaya from Princeton University to the Scientific Advisory Board
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio to Present at BofA Securities 2023 Health Care Conference
PR NewswirePacBio Announces Record Revenue in First Quarter 2023

Pacific Biosciences of California News

Pacific Biosciences of California News: auf dieser Seite finden Sie alle Pacific Biosciences of California News und Nachrichten zur Pacific Biosciences of California Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pacific Biosciences of California News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pacific Biosciences of California News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.